News | April 14, 2025
Nureca’s manufacturing subsidiary secures USFDA registration
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Encourages working women to practice self-care
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
Subscribe To Our Newsletter & Stay Updated
